Cannon, J G, Angel, J B, Ball, R W et al. · Journal of clinical immunology · 1999 · DOI
This study tested whether people with ME/CFS have abnormal levels of immune signaling molecules called cytokines, which could explain their symptoms. Researchers compared 10 ME/CFS patients with 11 healthy controls at rest and after 15 minutes of stepping exercise, measuring immune markers in their blood. They found that ME/CFS patients had higher baseline levels of certain inflammatory markers, but exercise responses were similar between groups.
Understanding whether immune dysregulation drives ME/CFS symptoms is crucial for identifying therapeutic targets. This early study systematically examined cytokine responses to exercise stress, a hallmark trigger in ME/CFS, providing foundational evidence that cytokine abnormalities may be a secondary feature rather than a primary cause.
This study does not prove that cytokines play no role in ME/CFS—only that the measured cytokines are not dramatically abnormal or the dominant pathogenic factor. The modest differences observed could still be clinically significant, and other unmeasured immune mediators may be important. Small sample size and single timepoint exercise challenge limit generalizability of findings.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →